p-Toluenesulfonic acid monohydrate (EBC-163021)
Back
Product details:
CAS
120511-73-1
Purity
95%
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor. Anastrozole is indicated as adjunct therapy in the treatment of hormone receptor-positive early breast cancer in postmenopausal women, and as a first-line treatment for hormone receptor-positive locally advanced or metastatic breast cancer in postmenopausal women.
Properties
Name
Anastrozole
Smiles
CC(C)(C#N)C=1C=C(CN2C=NC=N2)C=C(C1)C(C)(C)C#N
Targets
Please log in to see this information
SDS
Anastrozole | anastrazole | anastrozol | arimidex
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$50
2 mg
$52
5 mg
$53
10 mg
$62
15 mg
$67
20 mg
$72
25 mg
$80
30 mg
$88
35 mg
$96
40 mg
$104
45 mg
$112
50 mg
$120
75 mg
$140
100 mg
$150
Quantity
1
Total amount
$ 53
Anastrozole | anastrazole | anastrozol | arimidex
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.